Product
SA55
Aliases
SA55 Injection, SA55 nasal spray
3 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of Novel Coronavirus Broad-spectrum Neutralizing Antibody SA55 Injection in the Treatment of Mild/Moderate COVID-19 PatientsStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Phase I Clinical Trial to Evaluate the Safety, Tolerance and Pharmacokinetics of A Broad-Spectrum Neutralizing Antibodies SA55 Injection of COVID-19 in Healthy AdultsStatus: Recruiting, Estimated PCD: 2023-10-30
Clinical trial
A Phase I Clinical Study of Novel Coronavirus Broad-spectrum Neutralizing Antibody SA55 Nasal Spray in Healthy PeopleStatus: Recruiting, Estimated PCD: 2023-09-30